人工智能在药物发现中的应用与采用所面临的以数据为中心的挑战
Data-centric challenges with the application and adoption of artificial intelligence for drug discovery
AI总结:
本文探讨了AI在药物发现中面临的数据偏差、不确定性量化、评估误区及人类偏见等挑战,指出多数模型缺乏前瞻性价值,旨在为相关决策者提供参考。
摘要:
引言:人工智能(AI)正展现出巨大的潜力,有望降低药物发现的巨大成本和漫长周期。然而,目前存在一些重要的挑战,限制了AI模型的影响力和适用范围。涵盖领域:在这一视角中,作者讨论了一系列数据问题(偏差、不一致性、偏度、不相关性、小规模、高维度),它们如何挑战AI模型,以及哪些针对特定问题的缓解措施是有效的。接下来,他们指出了旨在增强和信任这些AI模型预测的不确定性量化技术所面临的挑战。他们还讨论了概念错误、不切实际的基准和性能误估如何混淆模型的评估,从而影响其发展。最后,作者解释了来自AI专家或药物发现专家的人类偏见如何构成另一项挑战,这可以通过积累更多前瞻性经验来缓解。专家意见:AI模型的开发通常是为了在回顾性基准上表现优异,而这些基准不太可能预测其前瞻性性能。因此,只有少数模型被报道具有前瞻性价值(例如,为治疗靶点发现有效且创新的药物先导化合物)。作者讨论了AI用于药物发现在实践中可能出错的地方。我们希望这将有助于该领域的编辑、资助者、投资者和研究人员做出明智决策。
英文摘要:
Introduction: Artificial intelligence (AI) is exhibiting tremendous potential to reduce the massive costs and long timescales of drug discovery. There are however important challenges currently limiting the impact and scope of AI models. Areas covered: In this perspective, the authors discuss a range of data issues (bias, inconsistency, skewness, irrelevance, small size, high dimensionality), how they challenge AI models, and which issue-specific mitigations have been effective. Next, they point out the challenges faced by uncertainty quantification techniques aimed at enhancing and trusting the predictions from these AI models. They also discuss how conceptual errors, unrealistic benchmarks and performance misestimation can confound the evaluation of models and thus their development. Lastly, the authors explain how human bias, whether from AI experts or drug discovery experts, constitutes another challenge that can be alleviated by gaining more prospective experience. Expert opinion: AI models are often developed to excel on retrospective benchmarks unlikely to anticipate their prospective performance. As a result, only a few of these models are ever reported to have prospective value (e.g. by discovering potent and innovative drug leads for a therapeutic target). The authors have discussed what can go wrong in practice with AI for drug discovery. We hope that this will help inform the decisions of editors, funders investors and researchers working in this area.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。